I forbindelse med administration af Naglazyme anbefales det, for at minimere den potentielle forekomst af IAR' er, at patienterne forbehandles med medicin (antihistaminer med eller uden antipyretika) cirka 30 – 60 minutter inden starten på infusionen.
With administration of Naglazyme it is recommended that patients be administered pre-treatment medications (antihistamines with or without antipyretics) approximately 30-60 minutes prior to the start of the infusion, to minimize the potential occurrence of IARs.